Spontaneous thymoma rat as a model for myasthenic weakness caused by anti-ryanodine receptor antibodies
Kazuo Iwasa MD
Department of Neurology, Kanazawa University School of Medicine, 13-1, Takara-machi, Kanazawa, 920-8640 Japan
Search for more papers by this authorKiyonobu Komai MD
Department of Neurology, Kanazawa University School of Medicine, 13-1, Takara-machi, Kanazawa, 920-8640 Japan
Search for more papers by this authorCorresponding Author
Masaharu Takamori MD
Department of Neurology, Kanazawa University School of Medicine, 13-1, Takara-machi, Kanazawa, 920-8640 Japan
Department of Neurology, Kanazawa University School of Medicine, 13-1, Takara-machi, Kanazawa, 920-8640 JapanSearch for more papers by this authorKazuo Iwasa MD
Department of Neurology, Kanazawa University School of Medicine, 13-1, Takara-machi, Kanazawa, 920-8640 Japan
Search for more papers by this authorKiyonobu Komai MD
Department of Neurology, Kanazawa University School of Medicine, 13-1, Takara-machi, Kanazawa, 920-8640 Japan
Search for more papers by this authorCorresponding Author
Masaharu Takamori MD
Department of Neurology, Kanazawa University School of Medicine, 13-1, Takara-machi, Kanazawa, 920-8640 Japan
Department of Neurology, Kanazawa University School of Medicine, 13-1, Takara-machi, Kanazawa, 920-8640 JapanSearch for more papers by this authorAbstract
The mechanism of muscle weakness in myasthenia gravis and its possible relation to antibodies that are directed against the ryanodine receptor (RyR) were studied by the use of the spontaneous thymoma rat (Buffalo/Mna strain). The present study focused on the motor dysfunction as complicated by impaired subcellular machineries and noted particularly in patients with thymus abnormalities. Rats began to develop skeletal muscle weakness soon after birth and worsened progressively. Rats aged 3 months showed a benign thymoma characterized by proliferative lymphocytes; epithelial cells were stained with anti-RyR peptide antibody. The rat serum contained anti-RyR antibodies, but no anti-acetylcholine receptor antibodies. The electrophysiological study in muscle showed a reduction of contractile force without abnormality in synaptic transmission and membrane properties, suggesting a defect in excitation–contraction coupling. Hypothetically, thymic epithelial cells and skeletal muscles share a common RyR antigen, so that anti-RyR antibodies that target the thymic tissue may react with a homologous target in the muscle. © 1998 John Wiley & Sons, Inc. Muscle Nerve 21: 1655–1660, 1998
References
- 1 Aarli JA, Stefansson K, Marton LSG, Wollmann RL: Patients with myasthenia gravis and thymoma have in their sera IgG autoantibodies against titin. Clin Exp Immunol 1990; 82: 284–288.
- 2
Amo H,
Saito M,
Nagao S,
Yagiu S,
Takahashi H,
Morita H,
Matsuyama-Morita T,
Matsuyama M:
Genetic regulation of slowly progressing mild muscle atrophy in fast-twitch muscles of BUF/Mna rats.
Muscle Nerve
1997;
20:
1258–1263.
10.1002/(SICI)1097-4598(199710)20:10<1258::AID-MUS8>3.0.CO;2-B CAS PubMed Web of Science® Google Scholar
- 3 Asaka T, Ishisaka K, Iwasa K, Takamori M: Striational autoantibodies in myasthenia gravis modulate calcium-induced calcium release from sarcoplasmic reticulum. Muscle Nerve 1994; suppl 1: S188.
- 4 Bártek J, Vojteek B, Stasková Z, Bártková J, Kerekés Z, Rejthar A, Kovarik J: A series of 14 new monoclonal antibodies to keratins: characterization and value in diagnostic histopathology. J Pathol 1991; 164: 215–224.
- 5 de Meis L, Hasselbach W: Acetylphosphate as substrate for Ca2+ uptake in skeletal muscle microsomes. J Biol Chem 1971; 246: 4759–4763.
- 6 Ezaki T, Kawatsu R, Matsuno K, Kotani M: Characterization of intrathymic and extrathymic T cell development in spontaneous thymoma Buffalo/Mna rats. Thymus 1990; 16: 67–87.
- 7 Ezaki T, Matsuno K, Kotani M: The thymic nurse cells (TNC) in spontaneous thymoma BUF/Mna rats as a model to study their roles in T-cell development. Immunology 1991; 73: 151–158.
- 8 Gilhus NE, Willcox N, Harcourt G, Nagvekar N, Beeson D, Vincent A, Newsom-Davis J: Antigen presentation by thymoma epithelial cells from myasthenia gravis patients to potentially pathogenic T cells. J Neuroimmunol 1995; 56: 65–76.
- 9 Hirokawa K, Utsuyama M, Kasai M, Konno A, Kurashima C, Moriizumi E: Age-related hyperplasia of the thymus and T-cell system in the Buffalo rat. Virchows Arch B Cell Pathol 1990; 59: 38–47.
- 10 Hohlfeld R, Wekerle H: The thymus in myasthenia gravis. Neurol Clin 1994; 12: 331–342.
- 11
Iwasa K:
Striational autoantibodies in myasthenia gravis mainly react with ryanodine receptor.
Muscle Nerve
1997;
20:
753–756.
10.1002/(SICI)1097-4598(199706)20:6<753::AID-MUS16>3.0.CO;2-V CAS PubMed Web of Science® Google Scholar
- 12 Kato F, Watanabe M: Motor dysfunction in spontaneous thymoma rats, Buffalo/Mna. J Pharm Dyn 1982; 5: 727–733.
- 13 Kuwajima G, Futatsugi A, Niinobe M, Nakanishi S, Mikoshiba K: Two types of ryanodine receptors in mouse brain: skeletal muscle type exclusively in Purkinje cells and cardiac muscle type in various neurons. Neuron 1992; 9: 1133–1142.
- 14 Levinson AI, Wheatley LM: The thymus and the pathogenesis of myasthenia gravis. Clin Immunol Immunopathol 1996; 78: 1–5.
- 15 Masuda A, Amo H, Matsuyama M: Cytological characteristics of cultured epithelial cells from thymomas in BUF/Mna rats. Virchows Arch B Cell Pathol 1984; 46: 283–296.
- 16 Matsuyama M, Suzuki H, Ito M, Yamada S, Nagayo T: Strain difference in carcinogenesis by urethan administration to sucking rats. Gann 1972; 63: 209–215.
- 17 Matsuyama M, Suzuki H, Yamada S, Ito M, Nagayo T: Ultrastructure of spontaneous and urethan-induced thymomas in Buffalo rats. Cancer Res 1975; 36: 2771–2779.
- 18 McPherson PS, Campbell KP: The ryanodine receptor/Ca2+ release channel. J Biol Chem 1993; 268: 13765–13768.
- 19 Meissner G: Ryanodine receptor/Ca2+ release channels and their regulation by endogeneous effectors. Annu Rev Physiol 1994; 56: 485–508.
- 20 Mygland Å, Tysnes O-B, Matre R, Volpe P, Aarli JA, Gilhus NE: Ryanodine receptor autoantibodies in myasthenia gravis patients with a thymoma. Ann Neurol 1992; 32: 589–591.
- 21 Mygland Å, Aarli JA, Matre R, Gilhus NE: Ryanodine receptor antibodies related to severity of thymoma-associated myasthenia gravis. J Neurol Neurosurg Psychiatry 1994; 57: 843–846.
- 22 Mygland Å, Kuwajima G, Mikoshiba K, Tysnes O-B, Aarli JA, Gilhus NE: Thymomas express epitopes shared by the ryanodine receptor. J Neuroimmunol 1995; 62: 79–83.
- 23 Ohta M, Ohta K, Itoh N, Kurobe M, Hayashi K, Nishitani H: Anti-skeletal muscle antibodies in the sera from myasthenic patients with thymoma: Identification of anti-myosin, actomyosin, actin, and α-actinin antibodies by a solid-phase radio-immunoassay and a Western blotting analysis. Clin Chem Acta 1990; 187: 255–264.
- 24 Pagala MKD, Nandakumar NV, Venkatachari SAT, Ravindran K, Numba T, Grob D: Responses of intercostal muscle biopsies from normal subjects and patients with myasthenia gravis. Muscle Nerve 1990; 13: 1012–1022.
- 25 Pagala M, Mandakumar NV, Venkatachari SAT, Ravindran K, Amaladevi B, Numba T, Grob D: Mechanisms of fatigue in normal intercostal muscle and muscle from patients with myasthenia gravis. Muscle Nerve 1993; 16: 911–921.
- 26 Takamori M, Okumura S, Yasuda A: Presynaptic modification of neuromuscular transmission by antiacetylcholine receptor antibody: myasthenic serum and monoclonal antibody produced by transformed lymphocytes. Neurology 1986; 36: 942–947.
- 27 Takamori M, Yoshikawa H: Effect of calcitonin gene-related peptide on skeletal muscle via specific binding site and G protein. J Neurol Sci 1989; 90: 99–109.
- 28 Takamori M, Hamada T, Komai K, Takahashi M, Yoshida A: Synaptotagmin can cuase an immune-mediated model of Lambert-Eaton myasthenic syndrome in rats. Ann Neurol 1994; 35: 74–80.
- 29 Takeshima H, Nishimura S, Matsumoto T, Ishida H, Kangawa K, Minamino N, Matsuo H, Ueda M, Hanaoka M, Hirose T, Numa S: Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor. Nature 1989; 339: 439–445.
- 30 Takeshima H, Iino M, Takekura H, Nishi M, Kuno J, Minowa O, Takano H, Noda T: Excitation-contraction uncoupling and muscular degeneration in mice lacking functional skeletal muscle ryanodine-receptor gene. Nature 1994; 369: 556–559.
- 31 Voltz RD, Albrich WC, Nägele A, Schumm F, Wick M, Freiburg A, Gautel M, Thaler HT, Aarli J, Kirchner TH, Hohlfeld R: Paraneoplastic myasthenia gravis: detection of anti-MGT 30 (titin) antibodies predicts thymic epithelial tumor. Neurology 1997; 49: 1454–1457.
- 32 Williams CL, Hay JE, Huiatt TW, Lennon VA: Paraneoplastic IgG striational autoantibodies produced by clonal thymic B cells and in serum of patients with myasthenia gravis and thymoma react with titin. Lab Invest 1992; 66: 331–336.
- 33 Yamada S, Masuko K, Ito M, Nagayo T: Spontaneous thymoma in Buffalo rats. Gann 1973; 64: 287–291.
- 34 Yamazawa T, Takeshima H, Shimuta M, Iino M: A region of the ryanodine receptor critical for excitation-contraction coupling in skeletal muscle. J Biol Chem 1997; 272: 8161–8164.
Citing Literature
